Brain+ at Altenpflege
Brain+ showcased at Danish Dementia Days & Altenpflege in Germany Following the market introduction of the first commercial version of its digital dementia care product, CST Assistant, in Denmark in Q4 2022 and in Germany in Q2 2023, Brain+ has scaled its go-to-market activities. As an essential component, this includes attendance and product showcasing at […]
BRAIN+ IN DEMENTIA CAFES IN GERMANY
Malteser Hilfsdienst and Brain+ begin collaboration to offer people with dementia access to CST in special dementia cafes in Germany Brain+ and Malteser Hilfsdienst has started a collaboration to help people with dementia in Germany. The Malteser Hilfsdienst is one of Germany’s major charitable service providers with over 1 million members and sponsors, and the organization is a major player in offering […]
New Digital Health Strategy in Germany
Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market This month the German Ministry of Health’s shared its new healthcare digitalization strategy, “Gemeinsam Digital”, together with a vision for an integrated digital health ecosystem in Germany. The country’s strong focus on digital solutions represents a great opportunity for Brain+ and other suppliers of digital therapeutics by enabling easier […]
First milestone met
Brain+ meets milestone with Rox Health (Roche Germany) Rox Health has approved the German version of Brain+’s first digital dementia product, CST-Therapist Companion, for commercial launch. Meeting this milestone unlocks access for Brain+ to additional expert resources in the Rox Health/Roche organization and triggers a minor milestone payment. The following milestones will be product launch […]
Accelerated launch Q2 2023
Brain+ partners with German medical distributor Advances launch of its first CST dementia product in Germany to Q2 2023 Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in Germany and begin to build the customer pipeline in preparation for the commercial launch of its first CST dementia product, […]
Germany opens the DiPA reimbursement pathway
Germany opens the DiPA reimbursement pathway to support the adoption of digital health applications, underpinning the value of the #1 target market for Brain+’ first commercial dementia product, CST A significant event for Brain+ as DiPA can provide reimbursement coverage for the first Cognitive Stimulation Therapy (CST) product, expected to be launched in Germany in […]
